The rheolytic thrombectomy AngioJet™ is a safe and technically feasible method for treating acute and sub-acute occluding lesions in the visceral arteries.

IF 1.5 4区医学 Q3 PERIPHERAL VASCULAR DISEASE International Angiology Pub Date : 2024-11-26 DOI:10.23736/S0392-9590.24.05326-4

Bachar Al Haj, Imam T Ritonga, Martin J Austermann, Marco V Usai

{"title":"The rheolytic thrombectomy AngioJet™ is a safe and technically feasible method for treating acute and sub-acute occluding lesions in the visceral arteries.","authors":"Bachar Al Haj, Imam T Ritonga, Martin J Austermann, Marco V Usai","doi":"10.23736/S0392-9590.24.05326-4","DOIUrl":null,"url":null,"abstract":"Background: The aim of this study is to evaluate the safety and feasibility of the AngioJet™ device in the endovascular treatment of visceral ischemia with stenotic or occlusive lesions.Methods: Retrospective analysis of patients treated for visceral artery occlusion with thrombectomy using the AngioJet™ (Boston Scientific, MA, USA). Inclusion criteria: patients with stenotic or occluding lesion in visceral arteries including renal and mesenteric arteries, who received endovascular treatment with AngioJet™.Results: Eighteen patients with acute and sub-acute visceral arteries occlusions underwent endovascular thrombectomy. In twelve cases the procedure was successful, and the patients were discharged with patent target arteries. Four cases required re-intervention and two cases ended with a fatal complication. The technical and clinical success rate in our study was 88,9% (sixteen out of eighteen), these patients were discharged from hospital with patent target arteries.Conclusions: The thrombectomy using the AngioJet™ device is an effective and feasible method for the treatment of stenotic or occluding lesions of the visceral arteries with rapid post-interventional clinical improvement and minimal adverse events.","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Angiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S0392-9590.24.05326-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The aim of this study is to evaluate the safety and feasibility of the AngioJet™ device in the endovascular treatment of visceral ischemia with stenotic or occlusive lesions.

Methods: Retrospective analysis of patients treated for visceral artery occlusion with thrombectomy using the AngioJet™ (Boston Scientific, MA, USA). Inclusion criteria: patients with stenotic or occluding lesion in visceral arteries including renal and mesenteric arteries, who received endovascular treatment with AngioJet™.

Results: Eighteen patients with acute and sub-acute visceral arteries occlusions underwent endovascular thrombectomy. In twelve cases the procedure was successful, and the patients were discharged with patent target arteries. Four cases required re-intervention and two cases ended with a fatal complication. The technical and clinical success rate in our study was 88,9% (sixteen out of eighteen), these patients were discharged from hospital with patent target arteries.

Conclusions: The thrombectomy using the AngioJet™ device is an effective and feasible method for the treatment of stenotic or occluding lesions of the visceral arteries with rapid post-interventional clinical improvement and minimal adverse events.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

流变溶栓 AngioJet™ 是治疗内脏动脉急性和亚急性闭塞病变的一种安全且技术上可行的方法。

背景：本研究旨在评估 AngioJet™ 设备在血管内治疗狭窄或闭塞病变的内脏缺血中的安全性和可行性：本研究旨在评估 AngioJet™ 设备在血管内治疗狭窄或闭塞病变的内脏缺血中的安全性和可行性：对使用 AngioJet™（波士顿科学公司，美国马萨诸塞州）进行血栓切除治疗的内脏动脉闭塞患者进行回顾性分析。纳入标准：接受 AngioJet™ 血管内治疗的内脏动脉（包括肾动脉和肠系膜动脉）狭窄或闭塞病变患者：18名急性和亚急性内脏动脉闭塞患者接受了血管内血栓切除术。其中 12 例手术成功，患者带着通畅的靶动脉出院。四例需要再次介入，两例以致命并发症告终。在我们的研究中，技术和临床成功率为88.9%（18例中有16例），这些患者都在靶动脉通畅的情况下出院：使用 AngioJet™ 设备进行血栓切除是治疗内脏动脉狭窄或闭塞病变的一种有效可行的方法，介入后临床症状迅速改善，不良反应极少。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

International Angiology 医学-外周血管病

CiteScore

2.80

自引率

28.60%

发文量

审稿时长

6-12 weeks

期刊介绍： International Angiology publishes scientific papers on angiology. Manuscripts may be submitted in the form of editorials, original articles, review articles, special articles, letters to the Editor and guidelines. The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work. Duties and responsibilities of all the subjects involved in the editorial process are summarized at Publication ethics. Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (ICMJE).